Eventide Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.6M Buy
498,202
+3,199
+0.6% +$213K 0.45% 74
2026
Q1
$31.1M Buy
495,003
+20,693
+4% +$1.44M 0.51% 68
2025
Q4
$31.5M Buy
+474,310
New +$30.7M 0.49% 72

Other funds holding DXCM

Eventide Asset Management's DXCM Position: Q2 2026 in Review

Eventide Asset Management increased its DexCom (DXCM) stake by 0.65% in Q2 2026, buying an estimated $213K and bringing the position to 498,202 shares worth $33.6M. The position accounts for 0.45% of the portfolio, ranked #74.

Eventide Asset Management first reported a position in DXCM in Q4 2025 and has held it in 3 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Eventide Asset Management held 498,202 shares of DexCom worth $33.6M as of Q2 2026.
  • Eventide Asset Management bought 3,199 DexCom shares in Q2 2026, an estimated $213K.
  • DexCom made up 0.45% of Eventide Asset Management's portfolio in Q2 2026, its #74 holding.
  • Eventide Asset Management first reported a position in DexCom in Q4 2025 and has held it in 3 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.